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“We are the world, we are the children”
Michael J. Jackson, Lionel B. Richie
Children undoubtedly represent 
the future of the world
As medical practitioners involved in 
Pediatrics we all have the responsibility of 
taking care of children. It is our responsibil-
ity to protect them from a variety of dangers, 
including, but not limited to, interruptions 
during pregnancy, genetic anomalies, peri-
natal injuries, congenital defects, malnutri-
tion, environmental diseases, infections, 
poverty, traumas, violence, and exploitation.
When we are in front of a sick child 
suffering, we should always ask ourselves: 
“What would you do if this were your child?”
“There comes a time when we heed a certain call
When the world must come together as one”
The new open-access journal “Frontiers 
in Pediatrics” will offer the experience and 
organization of specialized sections to serve 
all individuals interested in the care and the 
welfare of pediatric patients, from fetal life, 
through the perinatal and neonatal period, 
infancy, childhood, and adolescence, until 
the transitional age to adults.
Endless problems faced by sick children 
are still waiting for a solution, despite the 
most recent acquisitions:
a) Genetic disorders. The recent deco-
ding and sequencing of the human 
genome has expanded the horizon of 
possibilities in the diagnosis of genetic 
disorders. Researchers and scientists 
are now facing the difficulties of iden-
tifying strengths and limitations of the 
genome versus exome sequencing to 
identify the genetic causes of primary 
immunodeficiencies, before making 
the information available for potential 
clinical applications (1).
b) Pre-natal diagnosis. Substantial  progress 
has been made in the pre-natal epide-
miology in order to identify the conge-
nital heart malformations and facilitate 
the appropriate treatment as early as 
possible (2).
The traditional focus of neonatal scre-
ening for inherited metabolic diseases, 
which is responsible for significant mor-
bidity and mortality unless treatment is 
initiated early, is also moving toward a 
genetic and mutational scan across the 
whole fetal genome in a non-invasive 
manner by analyzing cell-free fetal DNA 
in the maternal blood as early as the 5th 
week of gestational age (3).
Epidemiological, clinical, cellular, and 
molecular evidence suggests that the 
conditions during fetal life play a criti-
cal role in developmental programing. 
Research on the biological mechani-
sms of fetal programing attracts inte-
rest and investigation, and telomere 
biology could represent the common 
underlying mechanism connecting 
fetal programing and subsequent 
health or susceptibility to complex 
disorders (4).
c) Prematurity. As a consequence of the 
improvement of pre-natal screening 
and diagnosis, the recognition of high-
risk neonates allowed the referral for 
delivery in proximity of high level 
Neonatal Intensive Care Units, with 
substantial benefits for the neonatal 
outcomes (5).
d) Neonatal physiology. Thanks to the intro-
duction of three-dimensional cardiac 
magnetic resonance with phase-contrast 
imaging, major progress has been achie-
ved in acquiring information on the neo-
natal physiology of the circulation, with 
the great advantage that this investigative 
technique can be performed in neonates 
without sedation or anesthesia (6).
e) Traumas. Recent studies have shown the 
unexpected evidence that the burden 
of permanent disability resulting from 
traumatic brain injuries among children 
is primarily accounted for by mild inju-
ries, rather than by severe injuries. As 
a result, efforts have to be addressed to 
prevent, not only severe, but also mild 
injuries to decrease the levels of disability 
following traumatic brain injuries (7).
f) Limited resources. Despite generalized 
attempts to diffuse globalization, diffi-
culties still exist in providing medical 
treatment to geographical areas which 
have difficult access and/or limited 
resources. This problem has been docu-
mented in the diagnosis of posterior 
urethral valve, where late referral and 
presentation are associated with high 
morbidity and mortality rates (8). Even 
if couples screening and educational 
programs have effectively decreased the 
rates of refusal in couples at risk for beta-
thalassemia major, most of the couples 
in certain geographical areas have a 
beta-thalassemia major child and rela-
ted socioeconomic problems, as their 
reasons for refusing pre-natal diagno-
sis or termination remain a challenge 
for the healthcare system even in recent 
years (9). Good results worldwide have 
been achieved with prevention and tre-
atment of asthma. Nevertheless socio-
economic and structural barriers for 
care within health services still remain 
obstacles to provide optimal treatment 
of asthma for many children (10).
g) Introducing new devices and new drugs. 
The research and development of 
drugs and devices for pediatric patients 
is complicated due to small patient 
populations, characteristics of pedia-
tric physiology and pathophysiology, 
practical and ethical difficulties in desi-
gning pre-clinical and clinical trials. 
In pre-clinical trials, it is challenging 
to identify appropriate  experimental 
models, clinically relevant efficacy end 
points, assessment of risks and benefits, 
and methods to monitor cardiovascu-
lar safety. Ethical concerns in pediatric 
clinical trials are due to consideration 
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educational model to support the 
design of patient safety is lacking, even 
though a number of theories have been 
suggested to guide educators in future 
instructional designs. Further research 
studies are required to explore which 
specific aspects of interventions are 
effective and why, and to assess whether 
such interventions can impact patient 
outcomes (21).
m) Influence of the life style of the parents. 
Obesity and the associated and related 
complications such as diabetes, hyper-
tension, cardiovascular, and respi-
ratory diseases represent the highest 
risk factor for mortality and morbi-
dity. Childhood obesity, a disturbingly 
growing problem, is directly related 
to the number of parent stressors. 
Parent-perceived stress is correlated to 
children’s fast-food consumption, an 
important behavioral indicator of obe-
sity risk. Addressing parent stressors 
and parent-perceived stress is needed 
in future research in studying the pre-
vention of child obesity (22).
n) Ethical and legal issues involved in pedia-
tric studies. Due to the contemporary 
regulatory framework for pediatric 
and neonatal research, and common 
problems in pediatric research over-
sight, challenges exist in pediatric 
research ethics, including balancing 
risk and benefit, informed consent 
and assent, and clinical equipments. 
Three areas of pediatric and neonatal 
research have been recently investiga-
ted in this respect: genomic screening, 
healthy children donating stem cells, 
and therapeutic hypothermia for neo-
nates with hypoxic–ischemic encepha-
lopathy (23). Even when consenting 
minors for genetic research and bio-
banking involves ethical and social 
challenges, other researchers proved 
that ethical, social, or legal issues were 
not the leading reasons for refusal of 
consent, demonstrating a high pedia-
tric consent rate (90%) comparable 
with that of adults (24).
o) Research tools in child health. The deve-
lopment and validation of research 
tools to measure the results of  medical 
and ambulatory care in pediatric 
patients are progressing. Recent studies 
have supported the validity of specific 
hydraulic network describing the entire 
circulatory system based on pre-stage 
two hemodynamics. This clinically 
validated multi-scale approach allows 
prediction of flow dynamics, cardiac 
output, mixed venous oxygen satura-
tion, and systemic and cerebral oxygen 
delivery (16). A strategy for reducing 
medication errors, morbidity, and mor-
tality in children, which have provided 
good results, is the use of a compute-
rized provider order entry, resulting 
in elimination of eligibility errors, 
ensuring completeness in prescribing 
fields, reduction in transcription errors, 
and improved prescribing practices 
through the use of clinical decision 
support (17). Future exploration of the 
development and implementation of 
computer-assisted learning in medical 
education can enhance the process and 
outcomes of medical education, despite 
the remaining issues of costs, opti-
mal design, use, and integration (18). 
Recently, researchers have extended 
upper and lower limbs robot-assisted 
therapy to children with neurologi-
cally based movement disorders arising 
from cerebral palsy and acquired brain 
injury or stroke. This new application 
could lead to new potential benefits to 
the pediatric population, despite the 
unavoidable challenges and needs for 
future development (19).
k) Application of nanotechnologies. Recent 
developments of nanotechnology in 
the field of cardiovascular diseases 
are emerging as a potential strategy 
in dealing with the complications and 
failures of the conventional treatments. 
Applications of nanotechnology in 
medicine are already underway, and 
offer tremendous potential for dia-
gnostics and therapeutic applications. 
Widely used biocompatible nano-
materials and nano-biotechnological 
tools have been utilized with high effi-
cacy for biomedical application, such 
as gene therapy, radiological imaging, 
targeted delivery systems, and vascular 
implants (20).
l) Education and training of the  care-givers. 
The importance of training non- 
technical skills is becoming increasingly 
prominent in the field of enhancing the 
safety of patients. So far a  recognized 
for the families. Due to the limitations 
of pre-marketing pediatric studies, 
post-marketing surveillance of both 
drugs and devices safety is compulsory 
in the pediatric population. Solutions 
for these issues require collabora-
tion between academia, industry, and 
government as well as creativity in desi-
gning pediatric studies (11).
h) Ambulatory monitoring and care. Since 
there is an evident trend to develop and 
manage healthcare services, it is vital 
to prevent errors in pediatric ambula-
tory care. The mistakes most frequently 
reported include failures in medical tre-
atment, communication, monitoring, 
patient identification, and the laboratory. 
Ongoing research is aimed at establi-
shing risk factors for these errors, achie-
ving effective interventions to enhance 
reporting and improve safety, in order 
to reduce adverse events and near mis-
ses (12). The development of wearable 
technology for bio-signal monitoring 
has been recently proved in preterm 
newborn care, validated by an in-hospi-
tal pre-clinical test demonstrating effi-
ciency, reliability, and quality (13).
i) Continuity of treatment from the pedia-
tric age through the transitional age. As 
a result of the advances in medical and 
surgical treatment during the pediatric 
age, most patients are now expected 
to live to adulthood, with a significant 
increase in the population of adults 
with congenital defects. Consequently, 
the transition from a pediatric primary 
care provider to an adult primary care 
system has become a critical process in 
health care management plans, addres-
sing the medical, psychosocial, and 
educational needs of adolescents and 
young adults with chronic physical and 
medical conditions. Useful examples 
derive from studies of transitional care 
for children with sickle cell disease (14) 
and congenital heart defects (15).
j) Introduction of mathematical models, 
computers, and robots incare and tea-
ching. Nowadays the mathematical 
models with computational fluid 
dynamics have reached a high level 
of sophistication. Nowadays a three-
dimensional computational model, 
developed by the finite volume method, 
can be coupled with an identical 
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The aim of “Frontiers in Pediatrics” is 
to become the tool available to make all 
“pediatricians” really work together and 
allow us to say “we’ll make a better day” for 
all children.
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questionnaires for assessing the level of 
youth  friendliness of family medicine 
services for research purposes, though 
further validations will be required to 
allow wider use of this tool in the future 
(25, 26).
When new discoveries are made available 
by the scientists involved in experimental 
and clinical research, the unavoidable con-
sequence is to stimulating more questions, 
more research, in an endless process toward 
knowledge.
“We can’t go on pretending day by day
That someone, somehow will soon make 
a change”
Whatever our field of involvement in 
the care of sick children, in basic science, 
experimental or clinical research, diag-
nostic investigations, medical or surgical 
treatment, we have a commitment: active 
participation to challenge the currently 
available paradigm in order to improve 
pediatric care.
The new journal “Frontiers in Pediatrics,” 
thanks to an open platform for mutual 
exchange, will be a terrific tool providing 
unexpected views and opinions in the on 
the pediatric field from all individuals and 
institutions with interest and motivation.
“We are the world, we are the children
We are the ones who make a brighter day
So let’s start giving”
Nowadays we don’t have any more valid 
excuses.
The time when scientists, researchers, 
and care-givers were allowed to remain 
in their own little kingdom, enjoying the 
confidence and the power given by their 
knowledge limited to a specific field, is gone.
Now is the time for all individuals and 
institutions dedicated to the care of children 
to start moving forward, independently 
of their specialized fields of involvement, 
sharing their knowledge, and joining their 
efforts toward a common goal.
This is an essential and timely step if 
we are to effectively address our pediatric 
health responsibilities.
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